FBT
$179.25
First Trust NYSE Arca Biotechnology Index Fund
Fund Family: First Trust Exchange-Traded Fund
Explore sections
1 Month
+3.56%
YTD
+6.41%
1 Year
+6.41%
3 Year
+35.73%
Top 10 Holdings (45.1% of portfolio)
- Corcept Therapeutics Inc.Financial Services7.70%
- BeiGene LtdUnknown5.18%
- Intra-Cellular Therapies IncUnknown4.67%
- Gilead Sciences IncManufacturing4.19%
- Halozyme Therapeutics, Inc.Manufacturing4.06%
- Amgen IncManufacturing3.99%
- Vertex Pharmaceuticals IncManufacturing3.98%
- MOTION FINCO SARLManufacturing3.95%
- Alnylam Pharmaceuticals IncManufacturing3.81%
- BioMarin Pharmaceutical IncManufacturing3.53%
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | Corcept Therapeutics Inc. | HTD | Financial Services | 7.70% |
| 2 | BeiGene Ltd | ONC | Unknown | 5.18% |
| 3 | Intra-Cellular Therapies Inc | ITCIEUR | Unknown | 4.67% |
| 4 | Gilead Sciences Inc | GILD | Manufacturing | 4.19% |
| 5 | Halozyme Therapeutics, Inc. | HALO | Manufacturing | 4.06% |
| 6 | Amgen Inc | AMGN | Manufacturing | 3.99% |
| 7 | Vertex Pharmaceuticals Inc | VRTX | Manufacturing | 3.98% |
| 8 | MOTION FINCO SARL | ALKS | Manufacturing | 3.95% |
| 9 | Alnylam Pharmaceuticals Inc | ALNY | Manufacturing | 3.81% |
| 10 | BioMarin Pharmaceutical Inc | BMRN | Manufacturing | 3.53% |
Fund Information
Net Assets$1.11B
Total Holdings32
Fund FamilyFirst Trust Exchange-Traded Fund